小分子免疫疗法治疗紫外炎的不断变化的景观:一个范围审查
Tammy S Y Yim1, Carlos Cifuentes-González2, Rupesh Agrawal3
1Singapore General Hospital, Singapore.
Drug discovery today
|October 29, 2025
概括
新兴的小分子药物显示出治疗非传染性脑膜炎 (NIU) 的前景,比较旧的治疗方法提供更好的眼睛透和有针对性的作用. 需要进一步的研究来证实它们在患者中的长期安全性和有效性.
科学领域:
- 眼科医生 眼科 眼科
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 非传染性眼膜炎 (NIU) 是一种严重的炎症性眼病.
- 目前的治疗方法,如皮质类固醇和生物药物有局限性,包括系统性毒性和眼球透率差.
研究的目的:
- 对NIU的小分子免疫疗法的最新进展进行审查.
- 识别具有潜在治疗益处的新型化合物和药物类别.
主要方法:
- 随机试验,观察性研究和动物模型的范围审查.
- 对16种药物类别和31种针对NIU炎症途径的新型化合物的分析.
主要成果:
- 一些小分子类,包括氨酸抑制剂,JAK抑制剂,mTOR抑制剂,皮质类固醇和RASP抑制剂,显示出有前途的临床疗效.
- 这些药物具有增强眼球透和精确细胞内调节的潜力.
- 与现有疗法相比,小分子可能会最大限度地降低全身毒性.
结论:
- 小分子免疫疗法代表了NIU治疗的有希望的新前沿.
- 这些药物可以克服当前的治疗局限性,并重新定义治疗模式.
- 需要进行更大规模的研究来验证NIU不同人群的长期安全性和有效性.
相关概念视频
Biopharmaceutical Factors Influencing Drug Product Design: Overview
232
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
232
Drug Products: Biologics, Biosimilars and Interchangeables
229
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
229
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
397
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
397
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
146
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
146
Therapeutic Drug Monitoring: Overview and Classification
304
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
304
Drug Administration and Therapy Phases: Overview
1.2K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.2K


